Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 12, 2014 - Issue 8
Submit an article Journal homepage
148
Views
12
CrossRef citations to date
0
Altmetric
Special Report

An overview of visceral leishmaniasis elimination program in India: a picture imperfect

Ubhayabharathi GurunathCorrespondence[email protected]
,
Rayanta JoshiSIRO Clinpharm Pvt Ltd, DIL Premises, Swami Vivekanand Road, Near Tatvagyan Vidyapeeth, Ghodbunder Road, Thane (W) 400 610, IndiaCorrespondence[email protected]
,
Ashish AgrawalSIRO Clinpharm Pvt Ltd, DIL Premises, Swami Vivekanand Road, Near Tatvagyan Vidyapeeth, Ghodbunder Road, Thane (W) 400 610, IndiaCorrespondence[email protected]
&
Vatsal ShahSIRO Clinpharm Pvt Ltd, DIL Premises, Swami Vivekanand Road, Near Tatvagyan Vidyapeeth, Ghodbunder Road, Thane (W) 400 610, India
Pages 929-935 | Published online: 14 Jun 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

H. V. Y. D Siriwardana, P. Karunanayake, L. Goonerathne & N. D. Karunaweera. (2017) Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat. Pathogens and Global Health 111:6, pages 317-326.
Read now

Articles from other publishers (11)

Ashutosh Paliwal, Rekha Gahtori, Amrita Kumari & Pooja Pandey. 2021. Pathogenesis, Treatment and Prevention of Leishmaniasis. Pathogenesis, Treatment and Prevention of Leishmaniasis 103 124 .
Emma Michelle Taylor. (2020) NTD Diagnostics for Disease Elimination: A Review. Diagnostics 10:6, pages 375.
Crossref
Rosa M. Reguera, Yolanda Pérez-Pertejo, Camino Gutiérrez-Corbo, Bárbara Domínguez-Asenjo, César Ordóñez, Carlos García-Estrada, María Martínez-Valladares & Rafael Balaña-Fouce. (2019) Current and promising novel drug candidates against visceral leishmaniasis. Pure and Applied Chemistry 91:8, pages 1385-1404.
Crossref
Shabnam Asfaram, Saeed Hosseini Teshnizi, Mahdi Fakhar, Elham Sadat Banimostafavi & Masoud Soosaraei. (2018) Is urine a reliable clinical sample for the diagnosis of human visceral leishmaniasis? A systematic review and meta-analysis. Parasitology International 67:5, pages 575-583.
Crossref
Emrah Şefik ABAMOR. (2018) A New Approach To The Treatment of Leıshmaniasis: Quercetin-Loaded Polycaprolactone Nanoparticles. Journal of the Turkish Chemical Society Section A: Chemistry 5:3, pages 1071-1082.
Crossref
S HENDRICKX, PJ GUERIN, G CALJON, SL CROFT & L MAES. (2016) Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology 145:4, pages 453-463.
Crossref
PAUL W. DENNY. (2017) Microbial protein targets: towards understanding and intervention. Parasitology 145:2, pages 111-115.
Crossref
Jacob T. Bush, Monique Wasunna, Fabiana Alves, Jorge Alvar, Piero L. Olliaro, Michael Otieno, Carol Hopkins Sibley, Nathalie Strub Wourgaft & Philippe J. Guerin. (2017) Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform. PLOS Neglected Tropical Diseases 11:9, pages e0005781.
Crossref
Om Prakash Singh, Epco Hasker, Marleen Boelaert & Shyam Sundar. (2016) Elimination of visceral leishmaniasis on the Indian subcontinent. The Lancet Infectious Diseases 16:12, pages e304-e309.
Crossref
Sarfaraz Ahmad Ejazi, Pradyot Bhattacharya, Md. Asjad Karim Bakhteyar, Aquil Ahmad Mumtaz, Krishna Pandey, Vidya Nand Ravi Das, Pradeep Das, Mehebubar Rahaman, Rama Prosad Goswami & Nahid Ali. (2016) Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India. PLOS Neglected Tropical Diseases 10:10, pages e0005035.
Crossref
Sarah Hendrickx, Annelies Leemans, Annelies Mondelaers, Suman Rijal, Basudha Khanal, Jean-Claude Dujardin, Peter Delputte, Paul Cos & Louis Maes. (2015) Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain. PLOS ONE 10:10, pages e0140139.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.